17.50
Precedente Chiudi:
$16.98
Aprire:
$17.27
Volume 24 ore:
44,915
Relative Volume:
0.26
Capitalizzazione di mercato:
$771.96M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+4.42%
1M Prestazione:
-16.51%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Sionna Therapeutics Inc Stock (SION) Company Profile
Nome
Sionna Therapeutics Inc
Settore
Industria
Telefono
617-819-2020
Indirizzo
21 HICKORY DRIVE, SUITE 500, WALTHAM
Confronta SION con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SION
Sionna Therapeutics Inc
|
17.50 | 772.93M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
377.80 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.49 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
430.89 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
667.94 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.19 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-04 | Iniziato | Guggenheim | Buy |
2025-03-04 | Iniziato | Stifel | Buy |
2025-03-04 | Iniziato | TD Cowen | Buy |
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
Is Sionna Therapeutics Inc. trending in predictive chart modelsIntraday Price Forecast Using Volume Models - Newser
Top chart patterns to watch in Sionna Therapeutics Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Is AMRN stock reversal real or fakeLong Term Stock Growth Plan Suggestions - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.Weekly Portfolio Update with ROI Focus - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionFree Sector Based Breakout Stock Forecast - Newser
What momentum shifts mean for Sionna Therapeutics Inc.Entry Zone Watchlist With Momentum Focus - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockChart-Based Entry Confirmation for Beginners - Newser
What’s next for Sionna Therapeutics Inc. stock priceWeekly Price Target Forecast and Alerts - Newser
What is the dividend policy of Sionna Therapeutics Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
Should I hold or sell Sionna Therapeutics Inc. stock in 2025Build wealth steadily with proven investment strategies - Jammu Links News
Is Sionna Therapeutics Inc. a growth stock or a value stockStay informed with expert market forecasts - Jammu Links News
Is Sionna Therapeutics Inc. stock overvalued or undervaluedUnlock daily stock market insights for success - Jammu Links News
What catalysts could drive Sionna Therapeutics Inc. stock higher in 2025Free Trend-Following Techniques - Jammu Links News
How strong is Sionna Therapeutics Inc. company’s balance sheetAccelerated financial growth - Jammu Links News
What makes Sionna Therapeutics Inc. stock price move sharplyExceptional ROI - Jammu Links News
How volatile is Sionna Therapeutics Inc. stock compared to the marketGet timely advice on market trends - Jammu Links News
Is it the right time to buy Sionna Therapeutics Inc. stockCapitalize on momentum-driven stocks - Jammu Links News
Does Sionna Therapeutics Inc. stock perform well during market downturnsRealize exceptional returns through smart trading - Jammu Links News
Intrinsic Value of Sionna Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Triple Return Setup with Risk Control - Newser
What is the risk reward ratio of investing in Sionna Therapeutics Inc. stockAI Powered Forecasts With Proven Results - Jammu Links News
What earnings revisions data tells us about Sionna Therapeutics Inc.Entry Opportunity Screener with Confirmation - Newser
Automated trading signals detected on Sionna Therapeutics Inc.Conservative Asset Allocation Risk Analysis - Newser
Key resistance and support levels for Sionna Therapeutics Inc.Short Term Momentum Based Trading Strategy - Newser
Can swing trading help recover from Sionna Therapeutics Inc. lossesOversold Opportunity Scanner with RSI Data - Newser
Traders Consider Averaging Down in Sionna Therapeutics Inc.Real Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
Sionna Therapeutics, Inc.’s Lock-Up Period To Expire on August 6th (NASDAQ:SION) - Defense World
Venture Co. Limited (OTCMKTS:VEMLY) Short Interest Update - Defense World
Published on: 2025-07-30 06:12:03 - metal.it
MACD Cross Could Confirm Trend in Sionna Therapeutics Inc.High Yield Stock Screening Results Explained - metal.it
Published on: 2025-07-29 22:11:07 - metal.it
Published on: 2025-07-29 13:11:50 - metal.it
Published on: 2025-07-28 23:06:16 - metal.it
Here's Why We're Not Too Worried About Sionna Therapeutics' (NASDAQ:SION) Cash Burn Situation - Yahoo Finance
Why is Sionna Therapeutics Inc. stock attracting strong analyst attentionFree Stock Market Mentorship - Jammu Links News
Sionna Therapeutics Inc Azioni (SION) Dati Finanziari
Non sono disponibili dati finanziari per Sionna Therapeutics Inc (SION). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Sionna Therapeutics Inc Azioni (SION) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
TPG GP A, LLC | 10% Owner |
Feb 10 '25 |
Buy |
18.00 |
1,125,000 |
20,250,000 |
6,684,962 |
RA CAPITAL MANAGEMENT, L.P. | Director |
Feb 10 '25 |
Buy |
18.00 |
1,125,000 |
20,250,000 |
6,923,365 |
ORBIMED ADVISORS LLC | Director |
Feb 10 '25 |
Buy |
18.00 |
550,000 |
9,900,000 |
3,704,959 |
Thompson Peter A. | Director |
Feb 10 '25 |
Buy |
18.00 |
550,000 |
9,900,000 |
3,704,959 |
Booth Bruce | Director |
Feb 10 '25 |
Buy |
18.00 |
60,000 |
1,080,000 |
807,727 |
Atlas Venture Fund XI, L.P. | 10% Owner |
Feb 10 '25 |
Buy |
18.00 |
60,000 |
1,080,000 |
807,727 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):